Transparency Life Sciences (TLS) is the world’s first drug development company based on open innovation. TLS acquires new chemical entities and repurposed generics that address significant unmet medical needs and tests them in clinical trials that leverage crowdsourcing methods, advances in telemedicine and full data transparency. The company expects this innovative approach to result in significantly reduced costs and clinical timelines.
